arrow
J

Jennifer S. Buell

Brandeis University
H指数:14
被引数:1,882

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy
2024-07-311
OAAI
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

中重度急性呼吸窘迫综合征不变自然杀伤T细胞治疗的1/2期临床试验

2024-02-066
OAAI
Molecular mechanism of phosphopeptide neoantigen immunogenicity (vol 14, 3763, 2023)
2023-07-270
OAAI
Expanding the therapeutic potential of anti-PD-1 and anti-CTLA-4 therapy with innovative Fc engineering and rationale combinations for the treatment of solid tumors
2020-08-150
PRE
Identification and validation of WRN as a novel synthetic lethality target in context of microsatellite instability
2020-08-150
PRE
INCAGN1949, an anti-OX40 antibody with an optimal agonistic profile and the ability to selectively deplete intratumoral regulatory T cells
2017-07-014
PRE
INCAGN1876, a unique GITR agonist antibody that facilitates GITR oligomerization
2017-07-014
PRE
Agenus' next generation cancer vaccine platforms
2017-07-010
PRE
AGEN1884, an IgG1 anti-CTLA-4 antibody, combines effectively with PD-1 blockade in primary human T cell assays and in a non-human primate pharmacodynamic (PD) model
2017-07-010
PRE